Screening of Thymoquinone Content in Commercial Nigella sativa Products to Identify a Promising and Safe Study Medication
Abstract
:1. Introduction
2. Materials and Methods
2.1. Samples
2.2. Chemicals
2.3. Analysis of Thymoquinone
2.3.1. Extraction
2.3.2. HPLC Analysis
2.3.3. Method Validation
3. Results and Discussion
3.1. Analytical Method
3.2. TQ Content
3.3. Safety and Efficacy
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Chrubasik-Hausmann, S. Schwarzkümmel. 2018. Available online: https://www.uniklinik-freiburg.de/fileadmin/mediapool/08_institute/rechtsmedizin/pdf/Addenda/Schwarzkümmel.pdf (accessed on 19 July 2022).
- Hannan, A.; Rahman, A.; Sohag, A.A.M.; Uddin, J.; Dash, R.; Sikder, M.H.; Rahman, S.; Timalsina, B.; Munni, Y.A.; Sarker, P.P.; et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021, 13, 1784. [Google Scholar] [CrossRef] [PubMed]
- Alkhatib, H.; Mawazi, S.M.; Al-Mahmood, S.M.A.; Zaiter, A.; Doolaanea, A.A. Thymoquinone content in marketed black seed oil in Malaysia. J. Pharm. Bioallied Sci. 2020, 12, 284–288. [Google Scholar] [CrossRef] [PubMed]
- Gad, H.A.; El-Ahmady, S.H. Prediction of thymoquinone content in black seed oil using multivariate analysis: An efficient model for its quality assessment. Ind. Crops Prod. 2018, 124, 626–632. [Google Scholar] [CrossRef]
- Botnick, I.; Xue, W.; Bar, E.; Ibdah, M.; Schwartz, A.; Joel, D.M.; Lev, E.; Fait, A.; Lewinsohn, E. Distribution of Primary and Specialized Metabolites in Nigella sativa Seeds, a Spice with Vast Traditional and Historical Uses. Molecules 2012, 17, 10159–10177. [Google Scholar] [CrossRef] [PubMed]
- Kaseke, T.; Opara, U.L.; Fawole, O.A. Novel seeds pretreatment techniques: Effect on oil quality and antioxidant properties: A review. J. Food Sci. Technol. 2021, 58, 4451–4464. [Google Scholar] [CrossRef]
- Burits, M.; Bucar, F. Antioxidant activity of Nigella sativa essential oil. Phytother. Res. 2000, 14, 323–328. [Google Scholar] [CrossRef]
- Bustamam, M.S.A.; Hadithon, K.A.; Mediani, A.; Abas, F.; Rukayadi, Y.; Lajis, N.; Shaari, K.; Ismail, I.S. Stability Study of Algerian Nigella sativa Seeds Stored under Different Conditions. J. Anal. Methods Chem. 2017, 2017, 7891434. [Google Scholar] [CrossRef]
- Kiralan, M.; Özkan, G.; Bayrak, A.; Ramadan, M.F. Physicochemical properties and stability of black cumin (Nigella sativa) seed oil as affected by different extraction methods. Ind. Crops Prod. 2014, 57, 52–58. [Google Scholar] [CrossRef]
- Mohammed, N.K.; Manap, M.Y.A.; Tan, C.P.; Muhialdin, B.J.; Alhelli, A.M.; Hussin, A.S.M. The Effects of Different Extraction Methods on Antioxidant Properties, Chemical Composition, and Thermal Behavior of Black Seed (Nigella sativa L.) Oil. Evid.-Based Complement. Altern. Med. 2016, 2016, 6273817. [Google Scholar] [CrossRef]
- Soliman, R.M.; Salam, R.A.A.; Eid, B.G.; Khayyat, A.; Neamatallah, T.; Mesbah, M.K.; Hadad, G.M. Stability study of thymoquinone, carvacrol and thymol using HPLC-UV and LC-ESI-MS. Acta Pharm. 2020, 70, 325–342. [Google Scholar] [CrossRef] [Green Version]
- Iqbal, M.S.; Ahmad, A.; Pandey, B. Solvent based optimization for extraction and stability of thymoquinone from Nigella sativa Linn. and its quantification using RP-HPLC. Physiol. Mol. Biol. Plants 2018, 24, 1209–1219. [Google Scholar] [CrossRef] [PubMed]
- Spiller, S.; Mettke, P.; Siehl, H.-U.; Zeller, K.-P.; Sicker, D.; Berger, S. Thymochinon—Das Gelbe vom Öl: Spät entdeckt. Chem. Zeit 2014, 48, 114–122. [Google Scholar] [CrossRef]
- Aboul-Enein, H.Y.; Abou-Basha, L.I. Simple HPLC Method for the Determination of Thymoquinone in Black Seed Oil (Nigella sativa Linn). J. Liq. Chromatogr. 1995, 18, 895–902. [Google Scholar] [CrossRef]
- Pathan, S.A.; Jain, G.K.; Zaidi, S.M.A.; Akhter, S.; Vohora, D.; Chander, P.; Kole, P.L.; Ahmad, F.J.; Khar, R.K. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies. Biomed. Chromatogr. 2011, 25, 613–620. [Google Scholar] [CrossRef] [PubMed]
- Ghosheh, O.A.; Houdi, A.A.; Crooks, P.A. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J. Pharm. Biomed. Anal. 1999, 19, 757–762. [Google Scholar] [CrossRef]
- Avula, B.; Ganzera, M.; Warnick, J.E.; Feltenstein, M.W.; Sufka, K.J.; Khan, I.A. High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. J. Chromatogr. Sci. 2004, 42, 378–382. [Google Scholar] [CrossRef] [PubMed]
- Hadad, G.M.; Salam, R.A.A.; Soliman, R.M.; Mesbah, M.K. High-Performance Liquid Chromatography Quantification of Principal Antioxidants in Black seed (Nigella sativa L.) Phytopharmaceuticals. J. AOAC Int. 2012, 95, 1043–1047. [Google Scholar] [CrossRef]
- Burdock, G.A. Assessment of black cumin (Nigella sativa L.) as a food ingredient and putative therapeutic agent. Regul. Toxicol. Pharmacol. 2021, 128, 105088. [Google Scholar] [CrossRef]
- Amini, M.; Huseini, H.F.; Mohtashami, R.; Sadeqhi, Z.; Ghamarchehre, M. Hypolipidemic Effects of Nigella sativa L. Seeds Oil in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J. Med. Plants 2011, 40, 133–138. [Google Scholar]
- Huseini, H.F.; Amini, M.; Mohtashami, R.; Ghamarchehre, M.E.; Sadeqhi, Z.; Kianbakht, S.; Huseini, A.F. Blood Pressure Lowering Effect of Nigella sativa L. Seed Oil in Healthy Volunteers: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. Phytother. Res. 2013, 27, 1849–1853. [Google Scholar] [CrossRef]
- Akrom, A.; Darmawan, E. Tolerability and Safety of Black Cumin Seed Oil (Bcso) Administration for 20 Days in Healthy Subjects. Biomed. Res. 2017, 28, 4196–4201. [Google Scholar]
- Al-Ali, A.; Alkhawajah, A.A.; Randhawa, M.A.; Shaikh, N.A. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J. Ayub Med. Coll Abbottabad 2008, 20, 25–27. [Google Scholar]
- Zaoui, A.; Cherrah, Y.; Alaoui, K.; Mahassine, N.; Amarouch, H.; Hassar, M. Effects of Nigella sativa fixed oil on blood homeostasis in rat. J. Ethnopharmacol. 2002, 79, 23–26. [Google Scholar] [CrossRef]
- Zaoui, A.; Cherrah, Y.; Mahassini, N.; Alaoui, K.; Amarouch, H.; Hassar, M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 2002, 9, 69–74. [Google Scholar] [CrossRef]
- Zaghlol, D.A.A.; Kamel, E.S.; Mohammed, D.S.; Abbas, N.H. The possible toxic effect of different doses of Nigella sativa oil on the histological structure of the liver and renal cortex of adult male albino rats. Egypt J. Histol. 2012, 35, 127–136. [Google Scholar] [CrossRef]
- Ramalingam, K.; Kuttan, R.; Sivadasan, S.D.; Ittiyavirah, S.; Madhavamenon, K.I. Safety Assessment of a Thymoquinone-rich Black Cumin Oil (BlaQmax®): Acute and Sub-chronic Toxicity Studies. J. Nutr. Food Sci. 2021, 11, 811. [Google Scholar]
- Thomas, J.V.; Mohan, M.E.; Prabhakaran, P.; Maliakel, B.; Krishnakumar, I.M. A phase I clinical trial to evaluate the safety of thymoquinone-rich black cumin oil (BlaQmax®) on healthy subjects: Randomized, double-blinded, placebo-controlled prospective study. Toxicol. Rep. 2022, 9, 999–1007. [Google Scholar] [CrossRef]
Sample | Product | Origin | Lot Number and Best before | Further Ingredients | Suggested Dose | Amount of Liquid in One Capsule |
---|---|---|---|---|---|---|
1 | Oil | Egypt | 1000016256 6.1.24 | None | Not stated | — |
2 | Oil | Egypt | 984082_2000_EG 25.2.24 | None | Not stated | — |
3 | Oil | Egypt | 0000098540 31.07.2024 | None | Not stated | — |
4 | Oil | Egypt | 202107.0179 30.10.22 | None | Not stated | — |
5 | Oil | Egypt | E18BS 27.1.23 | None | Not stated | — |
6 | Oil | Egypt | 2101791 31.01.2025 | Rosemary Extract, Tocopherols | Not stated | — |
7 | Oil in Capsules | Egypt | 2100676 30.6.24 | Vitamin E, Rosemary Extract | 3 Capsules per Day | 500 mg |
8 | Oil in Capsules | Egypt | 1900425 31.10.2021 | Rosemary Extract, Tocopherols | Not stated | 500 mg |
9 | Oil in Capsules | India | 28945A 3.11.23 | None | 2 Capsules per Day | 500 mg |
10 | Oil in Capsules | Egypt | 980377_1700_EG 6.7.24 | Natural Vitamin E, modified | 6 Capsules per Day | 760 mg |
11 | Oil in Capsules | Egypt | 2102609 30.4.25 | Vitamin E, Rosemary Extract | 3 Capsules per dDy | 500 mg |
Linearity | |||||
---|---|---|---|---|---|
Concentration range: 2.7–81 mg/L | Coefficient of determination R2: 0.9984 | ||||
Recovery ± standard deviation | Reference | ||||
100.0% ± 1.1% | Soliman et al. [11] | ||||
100% ± 2.5% | Aboul-Enein et al. [14] | ||||
Precision | |||||
Sample | Day | n | Mean Thymoquinone Content in mg/100 g | Intraday Relative Standard Deviation | Interday Relative Standard Deviation |
2 (oil) | 1 | 3 | 544.4 | 0.87% | 1.26% |
2 | 3 | 531.0 | 1.36% | ||
3 | 4 | 539.1 | 0.48% | ||
11 (capsules) | 1 | 3 | 45.1 | 1.88% | 7.54% |
2 | 3 | 44.0 | 5.83% | ||
3 | 4 | 39.0 | 2.87% |
Sample | Thymoquinone in mg/100 g (Mean) | SD | rel. SD | ||
---|---|---|---|---|---|
Oil Samples | |||||
1 | 133.9 | 0.24 | 0.18% | ||
2 | 538.2 | 7.02 | 1.30% | ||
3 | 172.4 | 0.90 | 0.52% | ||
4 | 138.9 | 1.25 | 0.90% | ||
5 | 809.4 | 2.69 | 0.33% | ||
6 | 45.26 | 4.67 | 10.3% | ||
Capsule Samples | Recommended Daily Dose in mg | TQ in Daily Dose in mg | |||
7 | 27.75 | 0.54 | 1.94% | 1500 | 0.416 |
8 | 3.08 | 0.88 | 28.7% | — | — |
9 | 660.5 | 0.88 | 0.13% | 1000 | 6.61 |
10 | 21.46 | 3.59 | 16.7% | 4560 | 0.979 |
11 | 42.33 | 3.21 | 7.58% | 1500 | 0.635 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Khaikin, E.; Chrubasik-Hausmann, S.; Kaya, S.; Zimmermann, B.F. Screening of Thymoquinone Content in Commercial Nigella sativa Products to Identify a Promising and Safe Study Medication. Nutrients 2022, 14, 3501. https://doi.org/10.3390/nu14173501
Khaikin E, Chrubasik-Hausmann S, Kaya S, Zimmermann BF. Screening of Thymoquinone Content in Commercial Nigella sativa Products to Identify a Promising and Safe Study Medication. Nutrients. 2022; 14(17):3501. https://doi.org/10.3390/nu14173501
Chicago/Turabian StyleKhaikin, Elisabeth, Sigrun Chrubasik-Hausmann, Sebahat Kaya, and Benno F. Zimmermann. 2022. "Screening of Thymoquinone Content in Commercial Nigella sativa Products to Identify a Promising and Safe Study Medication" Nutrients 14, no. 17: 3501. https://doi.org/10.3390/nu14173501
APA StyleKhaikin, E., Chrubasik-Hausmann, S., Kaya, S., & Zimmermann, B. F. (2022). Screening of Thymoquinone Content in Commercial Nigella sativa Products to Identify a Promising and Safe Study Medication. Nutrients, 14(17), 3501. https://doi.org/10.3390/nu14173501